Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Teva, El Al, Fibrolan, Tiv Textile: Israeli Equity Preview

Feb. 8 (Bloomberg) -- The following stocks may rise or fall in Israeli markets. Stock symbols are in parentheses after the company names and prices are from the close unless otherwise stated.

The TA-25 Index gained 0.3 percent to 1,323.68 in Tel Aviv.

El Al Israel Airlines Ltd. (ELAL IT): The country’s national airline agreed to buy four 737-900ER aircraft from Boeing Co., with an option to buy two additional planes. El Al advanced 0.8 percent to 1.476 shekels.

Fibrolan Ltd. (FIBR IT): The manufacturer of broadband access systems said its contract with Nokia Siemens Networks Australia has been extended through 2013. Fibrolan was unchanged at 3.349 shekels when it last traded Jan. 31.

Teva Pharmaceutical Industries Ltd. (TEVA IT): The world’s biggest generic-drugmaker reported fourth-quarter profit of $1.25 a share, missing the average estimate of $1.28 a share from 21 analysts surveyed by Bloomberg in the past month. Teva fell 0.6 percent to 200.70 shekels.

Tiv Textile Group 1969 Ltd. (TIVA IT): The maker of towels and bathrobes said it’s again supplying its customers in Egypt after halting deliveries last week because of the political situation there. Tiv Textile rose 5.7 percent to 9.59 shekels when it last traded Feb. 1.

To contact the reporters on this story: Calev Ben-David in Jerusalem at; Ronit Goodman in Tel Aviv at

To contact the editor responsible for this story: Claudia Maedler at

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.